1. BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cell-derived microenvironment through the MAPK/ERK and NF-κB pathways
    JING WANG et al, 2016 CrossRef
  2. Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer
    Oscar Juan et al, 2017, Clinical Lung Cancer CrossRef
  3. EUS-B-FNA vs conventional EUS-FNA for left adrenal gland analysis in lung cancer patients
    Laurence M.M.J. Crombag et al, 2017, Lung Cancer CrossRef
  4. Prognostic value of combining a quantitative image feature from positron emission tomography with clinical factors in oligometastatic non-small cell lung cancer
    Garrett L. Jensen et al, 2017, Radiotherapy and Oncology CrossRef
  5. Multiple Tumor Induction after Treatment of Temporal Arteritis with Prednisone
    Frank F. Piraino, 2017, Case Rep Oncol CrossRef
  6. Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival
    Praful R. Nair et al, 2018, Bioconjugate Chem. CrossRef
  7. Prevalence and risk factors of brain metastases in patients with newly diagnosed advanced non-small-cell lung cancer
    T. Duell et al, 2015, Cancer Treatment Communications CrossRef
  8. Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
    E E Vokes et al, 2018, Ann Oncol CrossRef
  9. Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner
    Meital Charni-Natan et al, 2018, Cell Death Dis CrossRef
  10. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study
    Jie Yang et al, 2018, J Cancer Res Clin Oncol CrossRef
  11. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer
    Amanda Jane Williams Gibson et al, 2018, Med Oncol CrossRef
  12. A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients
    Ida Netterberg et al, 2018, Clin. Pharmacol. Ther. CrossRef
  13. Pathologic differential diagnosis of metastatic carcinoma in the liver
    Jeong Hwan Park et al, 2018, Clin Mol Hepatol CrossRef
  14. A multi-gene expression profile panel for predicting liver metastasis: An algorithmic approach
    Kanisha Shah et al, 2018, PLoS ONE CrossRef
  15. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non–Small Cell Lung Cancer
    Asha Kandathil et al, 2018, RadioGraphics CrossRef
  16. Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
    Marc Schneider et al, 2018, Cancers CrossRef
  17. A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
    Cory Batenchuk et al, 2018, J Clin Pathol CrossRef
  18. From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
    Maria Protopapa et al, 2019, Journal of Oncology CrossRef
  19. Survival Implications of De Novo Versus Recurrent Metastatic Non–Small Cell Lung Cancer
    Sara Moore et al, 2019, American Journal of Clinical Oncology CrossRef
  20. Bowel obstruction caused by colonic metastasis of lung adenocarcinoma: a case report and literature review
    N. A. Parker et al, 2019, World J Surg Onc CrossRef
  21. null
    Marion W. Bergbauer et al, 2019 CrossRef
  22. Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.
    Sriram Sridhar et al, 2019, Clin Lung Cancer CrossRef
  23. Breast metastasis from primary lung adenocarcinoma in a young woman: A case report and literature review
    Diego Enrico et al, 2019, WJCO CrossRef
  24. The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer
    Jiasi Wang et al, 2019 CrossRef
  25. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis
    Jie Yang et al, 2019, Clin Exp Metastasis CrossRef
  26. Isolated squamous cell lung cancer metastasis to the scalp
    S. Taguchi et al, 2016, European Geriatric Medicine CrossRef
  27. Progression and metastasis of lung cancer.
    Helmut H Popper, 2016, Cancer Metastasis Rev CrossRef
  28. Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys
    Dean O. Campbell et al, 2016, Mol Imaging Biol CrossRef
  29. Real-World Clinical and Economic Outcomes and the Role of Bevacizumab in Patients With Non–Small-Cell Lung Cancer With Liver Metastases
    William B. Wong et al, 2019, JOP CrossRef
  30. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F
    Pauline Esteves et al, 2019, Oncogene CrossRef
  31. null
    Helmut Popper, 2017 CrossRef
  32. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
    Yuanqin Yin et al, 0 CrossRef
  33. Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
    Sol-Bi Shin et al, 2019, Oncogene CrossRef
  34. The Prognostic Factors for Long-term (≥5 Years) Survival in Stage IV Non-small Cell Lung Cancer
    Tatsu Matsuzaki et al, 2017, Haigan CrossRef
  35. Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
    Qinge Shan et al, 2019 CrossRef
  36. null
    Marion W. Bergbauer et al, 2020 CrossRef
  37. Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer
    Sara Pellegrino et al, 2019, Ann Nucl Med CrossRef
  38. Blood–Brain Barrier- and Blood–Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases
    Long Chen et al, 2019, ACS Appl. Mater. Interfaces CrossRef
  39. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
    Caryn Wujanto et al, 2019, Front. Oncol. CrossRef
  40. CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms
    José Raniery Ferreira-Junior et al, 2019, Int J CARS CrossRef
  41. In-vitro Pre-Treatment of Cancer Cells with TGF-β1: A Novel Approach of Tail Vein Lung Cancer Metastasis Mouse Model for Anti-Metastatic Studies
    Ghulam Jilany Khan et al, 2019, CMP CrossRef
  42. Multiple sites of soft-tissue metastases secondary to lung cancer
    Xingxing Zhu et al, 2019, Medicine CrossRef
  43. Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
    John Nikitas et al, 2019, Clinical and Translational Radiation Oncology CrossRef
  44. The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancer
    Bao-Dong Qin et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
  45. Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
    Claudia Ceci et al, 2020, IJMS CrossRef
  46. Comparative Study on Neutron Irradiation Sensitization Effects of Nucleotide Borate Esters and Several Other Boron Agents
    Miao Wang et al, 2020, Radiation Research CrossRef
  47. Metastatic Small-Cell Lung Cancer Presenting as Primary Adrenal Insufficiency
    Shawn Esperti et al, 2020, Case Reports in Oncological Medicine CrossRef
  48. Transcriptional suppression of AMPKα1 promotes breast cancer metastasis upon oncogene activation
    Yong Yi et al, 2020, Proc Natl Acad Sci USA CrossRef
  49. Liver metastases and the efficacy of the PD-1 or PD-L1 inhibitors in cancer: a meta-analysis of randomized controlled trials
    Shan Li et al, 2020, OncoImmunology CrossRef
  50. A live cell tracking NIR bioprobe for lung cancer cell metastasis monitoring
    Yufeng Li et al, 2020, Dyes and Pigments CrossRef
  51. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis
    Yijiu Ren et al, 2016, Oncotarget CrossRef
  52. A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis
    Aldo Pezzuto et al, 2019, Oncotarget CrossRef
  53. Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy
    Taiki Hakozaki et al, 2020, J Cancer Res Clin Oncol CrossRef
  54. Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
    Coral García-Fernández et al, 2020, Cancers CrossRef
  55. Imaging features and prognostic value of 18F-FDG PET/CT detection of soft-tissue metastasis from lung cancer: a retrospective study
    Tingting Xu et al, 2020, BMC Cancer CrossRef
  56. Tumor Primary Location May Affect Metastasis Pattern for Patients with Stage IV NSCLC: A Population-Based Study
    Qinge Shan et al, 2020, Journal of Oncology CrossRef
  57. miR‑338‑3p inhibits A549 lung cancer cell proliferation and invasion by targeting AKT and β‑catenin signaling pathways
    Jia Liu et al, 2019, Mol Med Report CrossRef
  58. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer
    In�s Ferreira et al, 2019, Int J Oncol CrossRef
  59. Candidate genes and pathways associated with brain metastasis from lung cancer compared with lymph node metastasis
    Xuelian Zhao et al, 2019, Exp Ther Med CrossRef
  60. Clinical associations and prognostic value of site‑specific metastases in non‑small cell lung cancer: A population‑based study
    Zihan Xu et al, 2019, Oncol Lett CrossRef
  61. Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage�IV non‑small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis
    Yi Liao et al, 2019, Oncol Lett CrossRef
  62. Targeting PD-L1 in non-small cell lung cancer using CAR T cells
    Ming Liu et al, 2020, Oncogenesis CrossRef
  63. null
    Emily C. Bartlett et al, 2020 CrossRef
  64. Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors
    Taiki Hakozaki et al, 2020, Journal of Geriatric Oncology CrossRef
  65. Longitudinal analysis of complete blood count parameters in advanced‐stage lung cancer patients
    Livia Rojko et al, 2020, Thorac Cancer CrossRef
  66. Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
    Begoña Campos‐Balea et al, 2020, Thorac Cancer CrossRef
  67. Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
    Janine M. DeBlasi et al, 2020, Cancers CrossRef
  68. Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
    Karam Khaddour et al, 2020, Front. Oncol. CrossRef
  69. Mesenchymal stem cells promote metastasis through activation of an ABL-MMP9 signaling axis in lung cancer cells
    Jing Jin Gu et al, 2020, PLoS ONE CrossRef
  70. Premetastasis
    Yoshiro Maru, 2020, Cold Spring Harb Perspect Med CrossRef
  71. New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
    Ramon Andrade de Mello et al, 2020, JCM CrossRef
  72. Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis
    Tianhao Zhu et al, 2020, Front. Oncol. CrossRef
    Harsha D.S et al, 2017, jebmh CrossRef
  74. Cytosolic serine hydroxymethyltransferase controls lung adenocarcinoma cells migratory ability by modulating AMP kinase activity
    Amani Bouzidi et al, 2020, Cell Death Dis CrossRef
  75. Development and Validation of a Novel Nomogram for Predicting Tumor-Distant-Metastasis in Patients with Early T1-2 Stage Lung Adenocarcinoma

    WeiGuo Gu et al, 2020, TCRM CrossRef
  76. Study of the co-expression gene modules of non-small cell lung cancer metastases
    Guanghui Wang et al, 2020, CBM CrossRef
  77. Prognostic impacts of extracranial metastasis on non‐small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database
    Miao Wang et al, 2020, Cancer Med CrossRef
  78. Stable W/O/W multiple nanoemulsion encapsulating natural tocotrienols and caffeic acid with cisplatin synergistically treated cancer cell lines (A549 and HEP G2) and reduced toxicity on normal cell line (HEK 293)
    Revathi Raviadaran et al, 2020, Materials Science and Engineering: C CrossRef
  79. Cutaneous Metastasis as the First Presentation of Non-Small-Cell Lung Cancer with a BRAF Mutation: A Case Report
    Xuejun Wang et al, 2020, OTT CrossRef
  80. To treat or not to treat: A rare case of response to pembrolizumab‐based immunotherapy‐chemotherapy in non‐small cell lung cancer with acute liver failure due to multiple bile duct metastases
    Inna Shaforostova et al, 2020, Thorac Cancer CrossRef
  81. Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agents
    Go Saito et al, 2021, Support Care Cancer CrossRef
  82. Role of microRNAs in Lung Carcinogenesis Induced by Asbestos
    Rakhmetkazhy Bersimbaev et al, 2021, JPM CrossRef
  83. Percutaneous cryoablation of adrenal metastases: technical feasibility and safety
    Hussein D. Aoun et al, 2021, Abdom Radiol CrossRef
  84. A rare case report: an inextricable shoulder pain as the exclusive presentation of lung adenocarcinoma with metastasis over contralateral clavicle
    Karl Wu et al, 2021, Eur J Med Res CrossRef
  85. Adenocarcinoma of the Lung With Inguinal Lymph Node Metastasis
    Venkatkiran Kanchustambham et al, 2021 CrossRef
  86. The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
    Shimin Xie et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  87. Liver metastases
    Diamantis I. Tsilimigras et al, 2021, Nat Rev Dis Primers CrossRef
  88. Temporal evolution of metastatic disease: part II—a novel proposal for subcategorization of metastatic disease from non-neural solid tumors with diverse histologies and locations
    Sireesha Yedururi et al, 2021, Jpn J Radiol CrossRef
  89. Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on serial oncologic imaging studies and relevant practical applications
    Nahyun Jo et al, 2021, Jpn J Radiol CrossRef
  90. “PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”
    Egesta Lopci et al, 2021, Seminars in Nuclear Medicine CrossRef
  91. Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors.
    Yue-Yun Chen et al, 2021, J Bone Oncol CrossRef
  92. “High Tumor Burden” in Metastatic Non-Small Cell Lung Cancer: Defining the Concept
    Oliver Higuera Gomez et al, 2021, CMAR CrossRef
  93. null
    Amnani Aminuddin et al, 2021 CrossRef
  94. Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
    Saikat Ghosh et al, 2021, Journal of Controlled Release CrossRef
  95. Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Angel Qin et al, 2021 CrossRef
  96. Lung Adenocarcinoma Metastatic to the Cervix: Report of a Rare Case and Review of the Literature
    Hossein Hosseini et al, 2021 CrossRef
  97. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454–3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC
    Yang Xia et al, 2021, Chemico-Biological Interactions CrossRef
  98. null
    Margherita Puppo et al, 2022 CrossRef
  99. Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway
    Yingying Wang et al, 2021 CrossRef
  100. null
    Bahman Rasuli et al, 2008 CrossRef
  101. Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer
    Tetsuya Isaka et al, 2021 CrossRef
  102. Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
    Annemarie C Eggen et al, 2021 CrossRef
  103. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
    A. Baydoun et al, 2021, Clinical and Translational Radiation Oncology CrossRef
  104. Extracellular Vesicles in Lung Cancer Metastasis and Their Clinical Applications
    Michela Saviana et al, 2021, Cancers CrossRef
  105. A small-molecule compound D6 overcomes EGFR-T790M-mediated resistance in non-small cell lung cancer
    Xiaolong Tang et al, 2021, Commun Biol CrossRef
  106. IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
    Naoyuki Nogami et al, 2021, Journal of Thoracic Oncology CrossRef
  107. Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial
    Ying Cheng et al, 2021, Cancer Medicine CrossRef
  108. Development of a human antibody fragment directed against the alpha folate receptor as a promising molecule for targeted application
    Nattihda Parakasikron et al, 2021, Drug Delivery CrossRef
  109. Usefulness of a Colonic Stent for Colonic Obstruction Caused by Lung Cancer Metastasis
    Mikito Suzuki et al, 2021, J Nippon Med Sch CrossRef
    Jofin George et al, 2021, ijsr CrossRef
  111. Frontline anti-PD-1/PD-L1 versus bevacizumab in advanced non-small-cell lung cancer: a network meta-analysis
    Jiarui Chen et al, 2022, Future Oncology CrossRef
  112. Predictive role of CYFRA 21-1 for S-1 monotherapy in non-small cell lung cancer patients
    Yusuke Kagawa et al, 2022, Respiratory Investigation CrossRef
  113. Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis
    Ruhan Zhao et al, 2022, Sci Rep CrossRef
  114. Extracellular vesicles promotes liver metastasis of lung cancer by ALAHM increasing hepatocellular secretion of HGF
    Chunyang Jiang et al, 2022, iScience CrossRef
  115. Spontaneous Rupture of the Renal Pelvis Due to Extrinsic Obstruction by Metastatic Retroperitoneal Lymphadenopathy
    Benjamin A Fink et al, 2022 CrossRef
  116. Establishment of prognostic nomograms for predicting the progression free survival of EGFR ‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs
    Xinyang Du et al, 2022, Thoracic Cancer CrossRef
  117. Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer
    Marcin Nicoś et al, 2022, Cancers CrossRef
  118. Percutaneous Radiofrequency Ablation Is an Effective Method for Local Control of Liver Metastases From Lung Cancer
    Zhong-Yi Zhang et al, 2022, Front. Oncol. CrossRef
  119. Machine Learning for the Prediction of Synchronous Organ-Specific Metastasis in Patients With Lung Cancer
    Huan Gao et al, 2022, Front. Oncol. CrossRef
  120. An Unusual Presentation of Duodenal Metastasis of a Previously Undiagnosed Primary Lung Adenocarcinoma
    Sai Karthik Kommineni et al, 2022 CrossRef
  121. Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis
    Wenjie Liu et al, 2022, Front. Immunol. CrossRef
  122. null
    Z. Hammoud et al, 2022 CrossRef
  123. Solitary pancreatic metastasis from squamous cell lung carcinoma: A case report and review of literature
    Kaouthar Rais et al, 2022, WJGE CrossRef
  124. Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study
    Shun Lu et al, 2022, Journal of Thoracic Oncology CrossRef
  125. Case Report: Lung Adenocarcinoma Initially Presenting With Cutaneous and Subcutaneous Metastases
    Jingjing Wang et al, 2022, Front. Oncol. CrossRef
  126. Efficacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial
    Anwen Xiong et al, 2022, Journal of Thoracic Oncology CrossRef
  127. RET signaling pathway and RET inhibitors in human cancer
    Angelina T. Regua et al, 2022, Front. Oncol. CrossRef
  128. Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
    Shun Lu et al, 2022, The Lancet Oncology CrossRef
  129. null
    Fiori Alite et al, 2022 CrossRef
  130. Effectiveness and safety of Osimertinib on non-small cell lung cancer therapy
    Xiaotian Wang, 2022, HSET CrossRef
  131. Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report
    Yuhao Luo et al, 2022, Front. Immunol. CrossRef
  132. Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
    S.M. Castenmiller et al, 2022, Immuno-Oncology and Technology CrossRef